advertisement
Advertisement (image not found)

Clinical Trials

ShareThis
Page
12345›»

QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR

QRxPharma announced today a successful interim analysis of its final MoxDuo...

Wednesday, September 01, 2010 Source: QRXPharma

ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By More Than 50 Percent In Patients With Geographic Atrophy In A Phase 2b Trial

ReVision Therapeutics Inc. today announced that data from a Phase 2b trial show...

Wednesday, September 01, 2010 Source: ReVision Therapeutics Inc.

Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirms Positive Findings Of First Trial

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ --

Tuesday, August 31, 2010 Source: ThromboGenics NV

Sangart, Inc. Reports Positive Phase IIa Data For Novel Oxygen Therapeutic Agent MP4OX In Severe Trauma Patients

Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept...

Tuesday, August 31, 2010 Source: Sangart, Inc.

Ortho-McNeil-Janssen Pharmaceuticals, Inc.'s Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Osteoarthritis Knee Pain; Announces Positive Results

RARITAN, N.J., Aug. 30 /PRNewswire/ -- Phase 3 safety and efficacy data comparing...

Tuesday, August 31, 2010 Source: PRNewswire

InSightec Treats First Prostate Cancer Patients In Clinical Trials

InSightec Ltd., the global leader in MR guided focused ultrasound technology...

Monday, August 30, 2010 Source: InSightec Ltd

Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients In Clinical Trials

TEL AVIV, Israel, August 31, 2010 /PRNewswire-FirstCall/ --

Monday, August 30, 2010 Source: Elbit Imaging Ltd.

Bionovo Receives Positive Guidance From FDA On Menerba®

Bionovo, Inc. announced today that it has received positive guidance from the U.S...

Monday, August 30, 2010 Source: Bionovo, Inc.

Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Osteoarthritis Knee Pain

Phase 3 safety and efficacy data comparing tapentadol extended release (ER)...

Monday, August 30, 2010 Source: PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Cell Therapy Foundation Calls For Additional Research, Extensive Clinical Trials

Some of the most promising medical research conducted to treat diseases of the...

Monday, August 30, 2010 Source: Cell Therapy Foundation
Page
12345›»

News Search

Search News By Keywords

News Sections

New Technologies

Blue Feulgen DNA Ploidy Analysis Staining Kit br
Blue Feulgen DNA Ploidy Analysis...
from ScyTek Laboratories
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading